A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Rationale: There is an urgent need for a platform to rapidly evaluate therapies in the outpatient setting, to prevent disease...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
